ATRA
Atara Biotherapeutics Inc
NASDAQ: ATRA · HEALTHCARE · BIOTECHNOLOGY
$4.77
+3.70% today
Updated 2026-04-30
Market cap
$40.97M
P/E ratio
1.95
P/S ratio
0.34x
EPS (TTM)
$2.57
Dividend yield
—
52W range
$4 – $19
Volume
0.3M
Atara Biotherapeutics Inc (ATRA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |